Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02458131 · ClinicalTrials.gov registry record · NA

Community-based Adolescent Diabetes Prevention Program

A NA study of Pre Diabetes, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT02458131 is a NA study of Pre Diabetes that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 90 participants, below the 728-participant average among 59 other Pre Diabetes trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02458131, a NA study of Pre Diabetes, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The number of youth with type 2 diabetes is predicted to quadruple by 2050, with a disproportionate increase among minority youth. The research proposed in this Career Development Award will use community-based participatory research methodology as well as novel strategies (peer education and mobile health technologies) to design, implement and evaluate a diabetes prevention intervention for at-risk ethnic minority youth in an urban community with high disease burden.

Conditions Studied

Interventions

  • BEHAVIORAL TEEN HEED

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2016-11-11
Est. Completion 2019-08-24
Phase NA

What the Registry Record Tells You About NCT02458131

The ClinicalTrials.gov registry entry for NCT02458131 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 728-participant average among 59 other Pre Diabetes trials with a reported enrollment target (88% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pre Diabetes appearing as the primary indexed condition, and to 1 intervention - of which TEEN HEED is the first listed.

NCT02458131 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02458131 about?

NCT02458131 is a clinical study titled "Community-based Adolescent Diabetes Prevention Program". The number of youth with type 2 diabetes is predicted to quadruple by 2050, with a disproportionate increase among minority youth. The research proposed in this Career Development Award will use community-based participatory research methodology as well as novel strategies (peer education and mobile...

What is the current status of trial NCT02458131?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2016-11-11. Estimated completion is 2019-08-24.

What conditions does trial NCT02458131 study?

This clinical trial studies the following conditions: Pre Diabetes.

What interventions are being tested in trial NCT02458131?

The interventions under investigation include: TEEN HEED (BEHAVIORAL).

Who is sponsoring clinical trial NCT02458131?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02458131 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pre Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.